HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis

Scandinavian Journal of Immunology

Volumn 43, Issue 1, 1996, Pages 101-108

  Duchmann, R ^a   May, E ^a   Ackermann, B ^a   Goergen, B ^a   Meyer Zum Buschenfelde K H ^a   Marker Hermann E ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BACTERIAL ANTIGEN; HLA B27 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; YERSINIA ENTEROCOLITICA;

EID: 0030064721     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-16.x     Document Type: Article

References (44)

1. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-6.
2. Aho K, Ahvonen P, Lassus A, Sievers K, Tilikainen A. HL-A antigen 27 and reactive arthritis. Lancet 1973;2:157-9.
3. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112.
4. Granfors K, Jalkanen S, von Essen R et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989;320:216-21.
5. Benjamin R, Parham P. HLA-B27 and disease: a consequence of inadvertent antigen presentation. Rheum Dis Clin N Am 1992;18:11-21.
6. Madden DR, Gorga JC, Strominger JL, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991;353:321-5.
7. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992;70:1035-48.
8. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991;353:326-9.
9. Caccia N, Mak TW. T cell receptors. Am J Med 1988;85:9-11.
10. Claverie JM, Prochnicka CA, Bougueleret L. Implications of a Fab-like structure for the T-cell receptor. Immunol Today 1989;10:10-4.
11. Chothia C, Boswell DR, Lesk AM. The outline structure of the T-cell alpha beta receptor. Embo J 1988;7:3745-55.
12. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988;334:395-401.
13. Bragado R, Lauzurica P, Lopez D, Lopez de Castro J. T cell receptor V beta gene usage in a human alloreactive response. Shared structural features among HLA-B27-specific T cell clones. J Exp Med 1990;171:1189-204.
14. Lauzurica P, Bragado R, Lopez D, Galocha B, Lopez de Castro J. Asymmetric selection of T cell antigen receptor alpha- and beta-chains in HLA-B27 alloreactivity. J Immunol 1992;148: 3624-30.
15. Bowness P, Moss PA, Rowland JS, Bell JI, McMichael AJ. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses. Eur J Immunol 1993;23:1417-21.
16. + T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995;154:3538-47.
17. Moss PA, Rosenberg WM, Bell JI. The human T cell receptor in health and disease. Annu Rev Immunol 1992;10:71-96.
18. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993;75:693-708.
19. von Boehmer H. Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol 1990;8:531-56.
20. Hermann E, Yu DT, Meyer zum Büschenfelde K-H, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993;342:646-50.
21. Hashim GA, Vandenbark AA, Galang AB et al. Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis. J Immunol 1990;144:4621-7.
22. Moder KG, Luthra HS, Kubo R, Griffiths M, David CS. Prevention of collagen induced arthritis in mice by treatment with an antibody directed against the T cell receptor alpha beta framework. Autoimmunity 1992;11:219-24.
23. Offner H, Hashim GA, Vandenbark AA. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 1991;251:430-2.
24. Beun G, van de Velde CJH, Fleuren GJ. T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition? Immunol Today 1994;15:11-15.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
26. Cho YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aurcus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1989;86:8941-5.
27. Genevee C, Diu A, Nierat J et al. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992;22:1261-9.
28. Hultman T, Ståhl S, Hornes E, Uhlén M. Direct solid phase sequencing of genomic DNA using magnetic beads as solid support. Nucleic Acids Research 1989;17:4937-46.
29. Tunnacliffe A, Kelford R, Milstein C, Forster A, Rabbitts TH. Sequence and evolution of the human T-cell antigen receptor beta-chain genes. Proc Natl Acad Sci USA 1985;82:5068-72.
30. Toyonaga B, Yoshikai Y, Vadasz V, Chin B, Mak TW. Organization and sequences of the diversity, joining and constant region genes of the human T cell receptor beta chain. Proc Natl Acad Sci USA 1986;82:8624-8.
31. Padovan E, Giachino C, Cella M, Valitutti S, Acuto O, Lanzavecchia A. Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion. J Exp Med 1995;181:1587-91.
32. Stuart PM, Woodward JG. Yersinia enterocolitica produces superantigenic activity. J Immunol 1992;148:225-33.
33. Jores R, Alzari PM, Meo T. Resolution of hypervariable regions in T-cell receptor β chains by a modified Wu-Kabat index of amino acid diversity. Proc Natl Acad Sci USA 1990;87:9138-42.
34. Acha-Orbea H, Mitchell DJ, Timmerman I et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specifc immune intervention. Cell 1988;54:263-73.
35. Hedrick SM, Engel SM, McElliott DL. Selection of amino acid sequences in the beta chain of the T cell antigen receptor. Science 1988;239:1541-2.
36. Herrmann T, MacDonald HR. The CD+ T cell response to staphylococcal enterotoxins. Semin Immunol 1993;5:33-9.
37. Chien YH, Davis MM. How alpha beta T-cell receptors 'see' peptide/MHC complexes. Immunol Today 1993;14:597-602.
38. Paliard X, West SG, Lafferty JA et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253: 325-9.
39. Sottini A, Imberti L, Gorla R, Cattanco R, Primi D. Restricted expression of T cell receptor V beta but not V alpha genes in rheumatoid arthritis. Eur J Immunol 1991;21:461-6.
40. + T-cell subsets. J Autoimmun 1993;6:621-37.
41. + T cells in Rheumatoid Arthritis. J Clin Invest 1994;94:2068-76.
42. Li Y, Sun GR, Tumang JR, Crow MK, Friedman SM. CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response. J Clin Invest 1994;94:2525-31.
43. Williams WV, Kieber ET, Fang Q et al. Conserved motifs in rheumatoid arthritis synovial tissue T-cell receptor beta chains. DNA Cell Biol 1993;12:425-34.
44. Howell MD, Diveley JP, Lundeen KA et al. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci USA 1991;88:10921-5.